Literature DB >> 23896509

Update in the treatment of high-grade Gliomas.

Rimas V Lukas1, Martin Kelly Nicholas.   

Abstract

Advances in the molecular classification of high-grade gliomas are laying the groundwork for potential changes in the treatment of high-grade gliomas. Currently, a combined modality approach involving surgery, radiation therapy, and chemotherapy is most often used in the treatment of high-grade gliomas. The authors review recent advances in the treatment of these primary brain tumors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Gliomas; Radiation therapy; Surgery

Mesh：

Substances：

Year:  2013        PMID： 23896509     DOI： 10.1016/j.ncl.2013.03.005

Source DB:  PubMed          Journal:  Neurol Clin        ISSN： 0733-8619            Impact factor:   3.806


  3 in total

1.  Down regulated expression of Claudin-1 and Claudin-5 and up regulation of β-catenin: association with human glioma progression.

Authors:  Hanuma K Karnati; Manas Panigrahi; Noor A Shaik; Nigel H Greig; S Appala R Bagadi; Mohammad A Kamal; Nagaiah Kapalavayi
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

2.  Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas.

Authors:  Yu-Chan Chang; Hsing-Fang Tsai; Shang-Pen Huang; Chi-Long Chen; Michael Hsiao; Wen-Chiuan Tsai
Journal:  Cancers (Basel)       Date:  2019-08-23       Impact factor: 6.639

3.  Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas.

Authors:  Yi-Hsuan Chen; Dueng-Yuan Hueng; Wen-Chiuan Tsai
Journal:  Int J Mol Sci       Date:  2018-10-26       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.